A new continuous OC that eliminates menstruation throughout the entire year has been shown to improve dysmenorrhea in a 1-year clinical trial presented at this year's ASRM meeting in Montreal.
A new continuous OC that eliminates menstruation throughout the entire year has been shown to improve dysmenorrhea in a 1-year clinical trial presented at this year's ASRM meeting in Montreal. The phase 3 study evaluated the effects of 20 μg of ethinyl estradiol and 90 μg of levonorgestrel in healthy women between the ages of 18 and 49 with a history of cycle-related symptoms, PMS, or dysmenorrhea. The OC significantly improved symptoms and boosted work productivity.
The researchers, who were supported by a grant from Wyeth, also concluded that the OC was more effective than selective serotonin reuptake inhibitors in treating PMS.
A related study, in which investigators did endometrial biopsies on the same group of women at baseline and 13 months into the trial, found that "histologic changes ....were consistent with a decrease in endometrial growth and decidualization."
Johnson JV, Grubb GS. Endometrial histology in subjects on a continuous use regimen of levo-norgestrel/ethinyl estradiol: results of a Phase 3 study. Fertil Steril. 2005;84(suppl 1):S170.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More